Litigation Details for GENZYME CORP. v. DR. REDDYS LABORATORIES, INC. (D.N.J. 2018)
✉ Email this page to a colleague
GENZYME CORP. v. DR. REDDYS LABORATORIES, INC. (D.N.J. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-11-20 |
| Court | District Court, D. New Jersey | Date Terminated | 2019-02-12 |
| Cause | 35:271 Patent Infringement | Assigned To | Brian R. Martinotti |
| Jury Demand | None | Referred To | Lois H. Goodman |
| Patents | 6,916,802; 7,196,205 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in GENZYME CORP. v. DR. REDDYS LABORATORIES, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for GENZYME CORP. v. DR. REDDYS LABORATORIES, INC. (D.N.J. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-11-20 | 1 | 6,890,949 B1 5/2005 Shayman et al. 6,916,802 B2 7/2005 Shayman et al. … infringement of U.S. Patent No. 7,196,205 (the “’205 patent”) under the Patent Laws of the United States… THE PATENT-IN-SUIT 21. On March 27, 2007, the ’205 patent, titled “Synthesis…United States Patent and Trademark Office (“PTO”). A true and correct copy of the ’205 patent is attached…the ’205 patent. 37. Defendants had actual knowledge of the ’205 patent prior to | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
